Skip to main content
. 2023 Jan 13;13(1):15. doi: 10.1038/s41408-023-00784-z

Fig. 4. Risk of second primary malignancies among patients with chronic lymphocytic leukemia according to the receipt of anti-neoplastic therapy.

Fig. 4

Statistically significant standardized incidence ratios and absolute excess risk are presented in bold in the table and as solid dark blue dots in the forest plot and are scaled according to their magnitude. AER absolute excess risk, CI confidence interval, SIR standardized incidence ratio.